Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00329524 · ClinicalTrials.gov registry record · NA

Using PET-CT to Target and Validate Low-frequency TMS as Treatment for Tinnitus

A NA study of Tinnitus, sponsored by University of Arkansas.

Completed
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT00329524 is a NA study of Tinnitus that has completed, run by University of Arkansas. The registered enrollment target is 5 participants, below the 12,620-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00329524, a NA study of Tinnitus, has completed, sponsored by University of Arkansas.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

One out of every five people experience tinnitus (a buzzing, ringing, or roaring sound in the ear) ranging from mild to severe impairment. To date there is no effective therapy that seems to help the tinnitus sufferer. The purpose of this study is to develop a therapy using a technique called Repetitive Transcranial Magnetic Stimulation (rTMS) to hopefully alleviate or reduce the symptoms of tinnitus. This research is being conducted at the University of Arkansas for Medical Sciences (UAMS). Up to twenty (20) right handed subjects, either males or females, 19-65 years of age, with tinnitus that is severe enough for those persons to seek medical attention will have been seen as patients in the UAMS Hearing and Balance Center, where routine testing includes a physical exam, hearing tests, evaluation of middle ear status, and an MRI scan (a machine that acquires visual images of the brain). A diagnosis of tinnitus will be established after ruling out all other possible causes of the tinnitus.

Conditions Studied

Interventions

  • DEVICE Repetitive Transcranial Magnetic Stimulation (rTMS)

Study Locations (1)

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2006-06
Est. Completion 2008-08
Phase NA

Sponsor

University of Arkansas

318 total trials

What the Registry Record Tells You About NCT00329524

The ClinicalTrials.gov registry entry for NCT00329524 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,620-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower). The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tinnitus appearing as the primary indexed condition, and to 1 intervention - of which Repetitive Transcranial Magnetic Stimulation (rTMS) is the first listed.

NCT00329524 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.

Frequently Asked Questions

What is clinical trial NCT00329524 about?

NCT00329524 is a clinical study titled "Using PET-CT to Target and Validate Low-frequency TMS as Treatment for Tinnitus". One out of every five people experience tinnitus (a buzzing, ringing, or roaring sound in the ear) ranging from mild to severe impairment. To date there is no effective therapy that seems to help the tinnitus sufferer. The purpose of this study is to develop a therapy using a technique called Repeti...

What is the current status of trial NCT00329524?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2006-06. Estimated completion is 2008-08.

What conditions does trial NCT00329524 study?

This clinical trial studies the following conditions: Tinnitus.

What interventions are being tested in trial NCT00329524?

The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (rTMS) (DEVICE).

Who is sponsoring clinical trial NCT00329524?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00329524 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tinnitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.